Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7420353rdf:typepubmed:Citationlld:pubmed
pubmed-article:7420353lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:7420353lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:7420353lifeskim:mentionsumls-concept:C0016278lld:lifeskim
pubmed-article:7420353lifeskim:mentionsumls-concept:C0028621lld:lifeskim
pubmed-article:7420353lifeskim:mentionsumls-concept:C0733755lld:lifeskim
pubmed-article:7420353lifeskim:mentionsumls-concept:C1555580lld:lifeskim
pubmed-article:7420353lifeskim:mentionsumls-concept:C1709634lld:lifeskim
pubmed-article:7420353pubmed:issue10lld:pubmed
pubmed-article:7420353pubmed:dateCreated1980-12-18lld:pubmed
pubmed-article:7420353pubmed:abstractTextSyntheses of five pairs of cytosine and 5-fluorocytosinexylofuranosyl nucleosides in which the 3'-hydroxyl group is replaced by Cl, Br, OMs, or OTs are described. Those xylosyl nucleosides with a good leaving group at the 3' position exhibit good inhibitory activity against L5178Y and P815 mouse leukemic cells in vitro at rather low concentrations, and like that of ara-C this cytotoxicity is reversed by 2'-deoxycytidine but not by thymidine. Xylosylcytosines are not active against ara-C resistant lines of L5178Y and P815 cells; however, the corresponding 5-fluorocytosine analogues exhibit significant cytotoxicity against these ara-C resistant leukemic cell lines, and this activity is reversed by thmidine but not by deoxycytidine. These data support the "double-barreled" masked precursor hypothesis in that xylosyl-5-fluorocytosines substituted at the 3' position by a good leaving group exhibit activity akin to that of ara-C in the ara-C sensitive lines, while these nucleosides act as 5-fluoropyrimidines in the ara-C resistant lines.lld:pubmed
pubmed-article:7420353pubmed:languageenglld:pubmed
pubmed-article:7420353pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7420353pubmed:citationSubsetIMlld:pubmed
pubmed-article:7420353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7420353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7420353pubmed:statusMEDLINElld:pubmed
pubmed-article:7420353pubmed:monthOctlld:pubmed
pubmed-article:7420353pubmed:issn0022-2623lld:pubmed
pubmed-article:7420353pubmed:authorpubmed-author:ChiC WCWlld:pubmed
pubmed-article:7420353pubmed:authorpubmed-author:WatanabeK AKAlld:pubmed
pubmed-article:7420353pubmed:authorpubmed-author:FoxJ JJJlld:pubmed
pubmed-article:7420353pubmed:authorpubmed-author:HollenbergD...lld:pubmed
pubmed-article:7420353pubmed:authorpubmed-author:ReichmanUUlld:pubmed
pubmed-article:7420353pubmed:issnTypePrintlld:pubmed
pubmed-article:7420353pubmed:volume23lld:pubmed
pubmed-article:7420353pubmed:ownerNLMlld:pubmed
pubmed-article:7420353pubmed:authorsCompleteYlld:pubmed
pubmed-article:7420353pubmed:pagination1088-94lld:pubmed
pubmed-article:7420353pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:7420353pubmed:meshHeadingpubmed-meshheading:7420353-...lld:pubmed
pubmed-article:7420353pubmed:meshHeadingpubmed-meshheading:7420353-...lld:pubmed
pubmed-article:7420353pubmed:meshHeadingpubmed-meshheading:7420353-...lld:pubmed
pubmed-article:7420353pubmed:meshHeadingpubmed-meshheading:7420353-...lld:pubmed
pubmed-article:7420353pubmed:meshHeadingpubmed-meshheading:7420353-...lld:pubmed
pubmed-article:7420353pubmed:meshHeadingpubmed-meshheading:7420353-...lld:pubmed
pubmed-article:7420353pubmed:meshHeadingpubmed-meshheading:7420353-...lld:pubmed
pubmed-article:7420353pubmed:year1980lld:pubmed
pubmed-article:7420353pubmed:articleTitleNucleosides. 116. 1-(beta-D-Xylofuranosyl)-5-fluorocytosines with a leaving group on the 3' position. Potential double-barreled masked precursors of anticancer nucleosides.lld:pubmed
pubmed-article:7420353pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:7420353lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7420353lld:pubmed